Source: WATER WARNING: Municipal water systems may be distribution vector for pandemic toxins
Carbon nanotubes and graphene are both low-dimensional sp2 carbon nanomaterials exhibiting many unique physical and chemical properties that are interesting in a wide range of areas including nanomedicine. Since 2004, carbon nanotubes have been extensively explored as drug delivery carriers for the intracellular transport of chemotherapy drugs, proteins, and genes. In vivo cancer treatment with carbon nanotubes has been demonstrated in animal experiments by several different groups. Recently, graphene, another allotrope of carbon, has also shown promise in various biomedical applications. In this article, we will highlight recent research on these two categories of closely related carbon nanomaterials for applications in drug delivery and cancer therapy, and discuss the opportunities and challenges in this rapidly growing field.
In the past decade, the rapid development of nanotechnology has brought many fascinating ideas and opportunities to disease diagnosis and treatment. sp2 carbon nanomaterials, notably zero-dimensional (0D) fullerenes, 1D carbon nanotubes (CNTs), and 2D graphene, have gained significant interest from various fields and generated huge impacts in the materials research community since their discovery in 1985, 1991, and 2004, respectively1, 2, 3. Graphene is a mono-layered sp2–bonded carbon sheet. Single-walled carbon nanotubes (SWNTs) and multi-walled carbon nanotubes (MWNTs) are cylindrical tubes of sp2 carbon, conceptualized by rolling up single- or multi-layered graphene, respectively. Potential applications of these carbon nanomaterials span disciplines including nano-electronics, composite materials, energy research, and biomedicine4, 5, 6, 7, 8, 9.
Fullerenes and their derivatives can serve as drug delivery vehicles, and in certain circumstances, as nano-drugs by themselves10, 11, 12. CNTs have been developed as novel biosensing platforms to detect different biological targets and as nano-probes for biomedical imaging8, 13, 14. Functionalized CNTs can be used as molecular carriers for in vitro and in vivo drug delivery, and have been primarily employed for applications in cancer treatment8.
Published on May 27, 2019
In this edition of Insider Insight, Dr. Dave chats with former Microsoft Canada President Frank Klegg about 5G wireless technology. This interview was made publically available due to overwhelming requests from Operation Freedom subscribers. For additional interviews and info on the Operation Freedom platform please visit: https://davejanda.com
THE 5G ROLLOUT: THE FUTURE OR A BETTER OPTION: Insider Insight – Frank Clegg – Part 2
Published on Apr 19, 2019
Oasis of HopePublished on Sep 10, 2013
Rick Hill was diagnosed with high-grade, embryonal-cell carcinoma in July of 1974. In October Hill had over ten hours of surgery at the Mayo Clinic, his cancer was now stage three, and chemotherapy was mandatory. Then, a friend of his told him about the Oasis of Hope Hospital on the beach in Tijuana, Mexico. It was a new concept then where they used anti-cancer treatments that were made from natural substances like Apricots. Sounded crazy but Mayo was not overly encouraging about his prognosis. Rick left for Oasis in October of ’74 and a couple of months later he had gained 20 pounds, his color came back, and he stayed on the dietary regime they prescribed for over many, many years. Rick volunteered to do some cooking shows for Oasis and a couple years later, they invited him to be the Admissions Director. He can be reached at 888-500-4673 and in less than 30 minutes he can make it possible for any cancer person to get a second opinion form a Surgical Oncologist at no charge! To learn more about treatments at Oasis of Hope, please visit www.oasisofhope.com
Published on Apr 2, 2019